Tenaya Therapeutics, Inc.
TNYAHealthcare|Biotechnology|US
$0.36
+0.04 (+13.99%)
DCF Value
$0.57
Tangible Book / Share
$0.24
Cash / Share
$0.30
Ownership Breakdown
92.9%
Float
227.9M
Shares Outstanding
211.7M
Float Shares
Major Holders (20)
Combined: 181.4%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Peter Svennilson | Individual | 23.10% | 49,313,559 | Feb 26, 2026 | 13D/G |
| The Column Group Opportunity III GP, LP | Partnership | 23.10% | 49,313,559 | Feb 26, 2026 | 13D/G |
| The Column Group Opportunity III, LP | Partnership | 23.10% | 49,313,559 | Feb 26, 2026 | 13D/G |
| Tim Kutzkey | Individual | 23.10% | 49,313,559 | Feb 26, 2026 | 13D/G |
| TCG Opportunity III GP, LLC | Other | 23.10% | 49,313,559 | Feb 26, 2026 | 13D/G |
| Israel A. Englander | Individual | 5.20% | 11,581,565 | Aug 24, 2026 | 13D/G |
| Millennium Group Management LLC | Other | 5.20% | 11,581,565 | Aug 24, 2026 | 13D/G |
| Millennium Management LLC | Other | 5.20% | 11,581,565 | Aug 24, 2026 | 13D/G |
| Integrated Core Strategies (US) LLC | Other | 5.20% | 11,579,445 | Aug 24, 2026 | 13D/G |
| Woodline Partners LP | IA, PN | 4.99% | 9,000,000 | Aug 14, 2025 | 13D/G |
| Ryan M. Lane | HC, IN | 4.99% | 8,296,276 | Jul 31, 2025 | 13D/G |
| Empery Asset Management, LP | IA, PN | 4.99% | 8,296,276 | Jul 31, 2025 | 13D/G |
| Martin D. Hoe | HC, IN | 4.99% | 8,296,276 | Jul 31, 2025 | 13D/G |
| Casdin Capital, LLC | Investment adviser | 4.30% | 6,732,971 | Mar 7, 2025 | 13D/G |
| Eli Casdin | Individual | 4.30% | 6,732,971 | Mar 7, 2025 | 13D/G |
| Casdin Partners Master Fund, L.P. | Partnership | 4.10% | 6,371,002 | Mar 7, 2025 | 13D/G |
| Casdin Partners GP, LLC | Other | 4.10% | 6,371,002 | Mar 7, 2025 | 13D/G |
| T. Rowe Price Associates, Inc. | Investment adviser | 3.80% | 3,028,435 | Nov 14, 2024 | 13D/G |
| Jpmorgan Chase & Co. | Holding company | 2.80% | 2,283,914 | Mar 6, 2025 | 13D/G |
| BlackRock, Inc. | Holding company | 1.70% | 2,732,800 | Jul 16, 2025 | 13D/G |
Insider Trades (100)
Last 4 quarters: 5,369,350 acquired · 7,819,522 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Ali Faraz | director, officer: Chief Executive Officer | Sep 10, 2026 | AWARD | 732,500 | $0.65 | $475.2K | Form 4 |
| Ali Faraz | director, officer: Chief Executive Officer | Sep 10, 2026 | AWARD | 122,000 | — | — | Form 4 |
| Tingley Whittemore | Chief Medical Officer | Sep 10, 2026 | AWARD | 293,000 | $0.65 | $190.1K | Form 4 |
| Tingley Whittemore | Chief Medical Officer | Sep 10, 2026 | AWARD | 49,000 | — | — | Form 4 |
| Ali Faraz | director, officer: Chief Executive Officer | Aug 17, 2026 | SELL | 5,837 | $0.71 | $4.1K | Form 4 |
| Ali Faraz | director, officer: Chief Executive Officer | Aug 17, 2026 | SELL | 3,969 | $0.71 | $2.8K | Form 4 |
| Ali Faraz | director, officer: Chief Executive Officer | Aug 17, 2026 | SELL | 5,020 | $0.71 | $3.6K | Form 4 |
| Ali Faraz | director, officer: Chief Executive Officer | Aug 17, 2026 | SELL | 7,406 | $0.71 | $5.3K | Form 4 |
| Tingley Whittemore | Chief Medical Officer | Aug 17, 2026 | SELL | 1,637 | $0.71 | $1.2K | Form 4 |
| Tingley Whittemore | Chief Medical Officer | Aug 17, 2026 | SELL | 1,637 | $0.71 | $1.2K | Form 4 |
| Tingley Whittemore | Chief Medical Officer | Aug 17, 2026 | SELL | 1,871 | $0.71 | $1.3K | Form 4 |
| Tingley Whittemore | Chief Medical Officer | Aug 17, 2026 | SELL | 2,279 | $0.71 | $1.6K | Form 4 |
| Hyllengren Eric J | Jul 13, 2026 | OTHER | 0 | — | — | Form 4 | |
| Hyllengren Eric J | Chief Financial Officer | Jul 13, 2026 | AWARD | 1,650,000 | $0.84 | $1.4M | Form 4 |
| Williams R Sanders | director | May 28, 2026 | AWARD | 120,000 | $0.80 | $95.9K | Form 4 |
| Walsh Jeffrey T. | director | May 28, 2026 | AWARD | 120,000 | $0.80 | $95.9K | Form 4 |
| Stehman-Breen Catherine | director | May 28, 2026 | AWARD | 120,000 | $0.80 | $95.9K | Form 4 |
| Srivastava Deepak | director | May 28, 2026 | AWARD | 120,000 | $0.80 | $95.9K | Form 4 |
| Parschauer Karah Herdman | director | May 28, 2026 | AWARD | 120,000 | $0.80 | $95.9K | Form 4 |
| Lee June | director | May 28, 2026 | AWARD | 120,000 | $0.80 | $95.9K | Form 4 |
| Burroughs Amy L. | director | May 28, 2026 | AWARD | 120,000 | $0.80 | $95.9K | Form 4 |
| Ali Faraz | director, officer: Chief Executive Officer | May 18, 2026 | SELL | 3,390 | $0.79 | $2.7K | Form 4 |
| Tingley Whittemore | Chief Medical Officer | May 18, 2026 | SELL | 3,121 | $0.79 | $2.5K | Form 4 |
| Higa Tomohiro | SVP, Finance | May 18, 2026 | SELL | 1,485 | $0.79 | $1.2K | Form 4 |
| COLUMN GROUP III GP, LP | 10 percent owner | Feb 24, 2026 | SELL | 349,212 | $0.62 | $214.9K | Form 4 |
| COLUMN GROUP III GP, LP | 10 percent owner | Feb 24, 2026 | SELL | 309,228 | $0.62 | $190.3K | Form 4 |
| COLUMN GROUP III GP, LP | 10 percent owner | Feb 25, 2026 | SELL | 1,862,545 | $0.56 | $1.0M | Form 4 |
| COLUMN GROUP III GP, LP | 10 percent owner | Feb 20, 2026 | SELL | 277,769 | $0.61 | $170.8K | Form 4 |
| COLUMN GROUP III GP, LP | 10 percent owner | Feb 23, 2026 | SELL | 162,291 | $0.60 | $96.9K | Form 4 |
| COLUMN GROUP III GP, LP | 10 percent owner | Feb 20, 2026 | SELL | 245,965 | $0.61 | $151.2K | Form 4 |
| COLUMN GROUP III GP, LP | 10 percent owner | Feb 23, 2026 | SELL | 143,709 | $0.60 | $85.8K | Form 4 |
| Higa Tomohiro | SVP, Finance | Feb 17, 2026 | SELL | 611 | $0.64 | $393.12 | Form 4 |
| Higa Tomohiro | SVP, Finance | Feb 17, 2026 | SELL | 836 | $0.64 | $537.88 | Form 4 |
| Higa Tomohiro | SVP, Finance | Feb 17, 2026 | SELL | 2,022 | $0.64 | $1.3K | Form 4 |
| Ali Faraz | director, officer: Chief Executive Officer | Feb 17, 2026 | SELL | 5,851 | $0.64 | $3.8K | Form 4 |
| Ali Faraz | director, officer: Chief Executive Officer | Feb 17, 2026 | SELL | 3,979 | $0.64 | $2.6K | Form 4 |
| Ali Faraz | director, officer: Chief Executive Officer | Feb 17, 2026 | SELL | 5,032 | $0.64 | $3.2K | Form 4 |
| Tingley Whittemore | Chief Medical Officer | Feb 17, 2026 | SELL | 1,642 | $0.64 | $1.1K | Form 4 |
| Tingley Whittemore | Chief Medical Officer | Feb 17, 2026 | SELL | 1,642 | $0.64 | $1.1K | Form 4 |
| Tingley Whittemore | Chief Medical Officer | Feb 17, 2026 | SELL | 1,876 | $0.64 | $1.2K | Form 4 |
| COLUMN GROUP III GP, LP | 10 percent owner | Feb 10, 2026 | SELL | 182,295 | $0.82 | $148.8K | Form 4 |
| COLUMN GROUP III GP, LP | 10 percent owner | Feb 10, 2026 | SELL | 161,422 | $0.82 | $131.7K | Form 4 |
| COLUMN GROUP III GP, LP | 10 percent owner | Feb 11, 2026 | SELL | 2,151,458 | $0.68 | $1.5M | Form 4 |
| COLUMN GROUP III GP, LP | 10 percent owner | Feb 11, 2026 | SELL | 1,905,115 | $0.68 | $1.3M | Form 4 |
| Higa Tomohiro | SVP, Finance | Feb 3, 2026 | AWARD | 175,500 | $0.92 | $160.6K | Form 4 |
| Higa Tomohiro | SVP, Finance | Feb 3, 2026 | AWARD | 29,250 | — | — | Form 4 |
| Tingley Whittemore | Chief Medical Officer | Feb 3, 2026 | AWARD | 318,500 | $0.92 | $291.4K | Form 4 |
| Tingley Whittemore | Chief Medical Officer | Feb 3, 2026 | AWARD | 48,750 | — | — | Form 4 |
| Ali Faraz | director, officer: Chief Executive Officer | Feb 3, 2026 | AWARD | 952,250 | $0.92 | $871.3K | Form 4 |
| Ali Faraz | director, officer: Chief Executive Officer | Feb 3, 2026 | AWARD | 158,600 | — | — | Form 4 |
| Higa Tomohiro | SVP, Finance | Nov 17, 2025 | SELL | 1,367 | $1.33 | $1.8K | Form 4 |
| Tingley Whittemore | Chief Medical Officer | Nov 17, 2025 | SELL | 2,877 | $1.33 | $3.8K | Form 4 |
| Ali Faraz | director, officer: Chief Executive Officer | Nov 17, 2025 | SELL | 3,126 | $1.33 | $4.2K | Form 4 |
| Higa Tomohiro | SVP, Finance | Aug 18, 2025 | SELL | 523 | $1.25 | $655.32 | Form 4 |
| Higa Tomohiro | SVP, Finance | Aug 18, 2025 | SELL | 717 | $1.25 | $898.40 | Form 4 |
| Higa Tomohiro | SVP, Finance | Aug 18, 2025 | SELL | 1,722 | $1.25 | $2.2K | Form 4 |
| Tingley Whittemore | Chief Medical Officer | Aug 18, 2025 | SELL | 1,608 | $1.25 | $2.0K | Form 4 |
| Tingley Whittemore | Chief Medical Officer | Aug 18, 2025 | SELL | 1,608 | $1.25 | $2.0K | Form 4 |
| Tingley Whittemore | Chief Medical Officer | Aug 18, 2025 | SELL | 1,837 | $1.25 | $2.3K | Form 4 |
| Ali Faraz | director, officer: Chief Executive Officer | Aug 18, 2025 | SELL | 5,720 | $1.25 | $7.2K | Form 4 |
| Ali Faraz | director, officer: Chief Executive Officer | Aug 18, 2025 | SELL | 3,893 | $1.25 | $4.9K | Form 4 |
| Ali Faraz | director, officer: Chief Executive Officer | Aug 18, 2025 | SELL | 4,920 | $1.25 | $6.2K | Form 4 |
| Stehman-Breen Catherine | director | May 29, 2025 | AWARD | 107,400 | $0.44 | $47.7K | Form 4 |
| Walsh Jeffrey T. | director | May 29, 2025 | AWARD | 107,400 | $0.44 | $47.7K | Form 4 |
| Burroughs Amy L. | director | May 29, 2025 | AWARD | 107,400 | $0.44 | $47.7K | Form 4 |
| GOEDDEL DAVID V | director, 10 percent owner: | May 29, 2025 | AWARD | 107,400 | $0.44 | $47.7K | Form 4 |
| Williams R Sanders | director | May 29, 2025 | AWARD | 107,400 | $0.44 | $47.7K | Form 4 |
| Srivastava Deepak | director | May 29, 2025 | AWARD | 107,400 | $0.44 | $47.7K | Form 4 |
| Lee June | director | May 29, 2025 | AWARD | 107,400 | $0.44 | $47.7K | Form 4 |
| Parschauer Karah Herdman | director | May 29, 2025 | AWARD | 107,400 | $0.44 | $47.7K | Form 4 |
| Higa Tomohiro | SVP, Finance | May 16, 2025 | SELL | 1,390 | $0.44 | $615.35 | Form 4 |
| Tingley Whittemore | Chief Medical Officer | May 16, 2025 | SELL | 2,937 | $0.44 | $1.3K | Form 4 |
| Ali Faraz | director, officer: Chief Executive Officer | May 16, 2025 | SELL | 3,189 | $0.44 | $1.4K | Form 4 |
| Higa Tomohiro | SVP, Finance | Mar 10, 2025 | SELL | 1,017 | $0.54 | $547.55 | Form 4 |
| Higa Tomohiro | SVP, Finance | Mar 10, 2025 | SELL | 620 | $0.54 | $333.81 | Form 4 |
| Higa Tomohiro | SVP, Finance | Mar 10, 2025 | SELL | 845 | $0.54 | $454.95 | Form 4 |
| Tingley Whittemore | Chief Medical Officer | Mar 10, 2025 | SELL | 1,727 | $0.54 | $929.82 | Form 4 |
| Tingley Whittemore | Chief Medical Officer | Mar 10, 2025 | SELL | 4,073 | $0.54 | $2.2K | Form 4 |
| Tingley Whittemore | Chief Medical Officer | Mar 10, 2025 | SELL | 1,598 | $0.54 | $860.36 | Form 4 |
| Ali Faraz | director, officer: Chief Executive Officer | Mar 10, 2025 | SELL | 5,794 | $0.54 | $3.1K | Form 4 |
| Ali Faraz | director, officer: Chief Executive Officer | Mar 10, 2025 | SELL | 3,947 | $0.54 | $2.1K | Form 4 |
| COLUMN GROUP III GP, LP | 10 percent owner | Mar 5, 2025 | BUY | 35,714,284 | $0.70 | $25.0M | Form 4 |
| COLUMN GROUP III GP, LP | 10 percent owner | Mar 5, 2025 | BUY | 35,714,284 | $0.80 | $28.6M | Form 4 |
| COLUMN GROUP III GP, LP | 10 percent owner | Mar 5, 2025 | BUY | 17,857,142 | $0.70 | $12.5M | Form 4 |
| GOEDDEL DAVID V | director, 10 percent owner: | Mar 5, 2025 | BUY | 35,714,284 | $0.70 | $25.0M | Form 4 |
| GOEDDEL DAVID V | director, 10 percent owner: | Mar 5, 2025 | BUY | 35,714,284 | $0.80 | $28.6M | Form 4 |
| GOEDDEL DAVID V | director, 10 percent owner: | Mar 5, 2025 | BUY | 17,857,142 | $0.70 | $12.5M | Form 4 |
| Higa Tomohiro | SVP, Finance | Feb 6, 2025 | OTHER | 0 | — | — | Form 4 |
| Higa Tomohiro | SVP, Finance | Feb 6, 2025 | OTHER | 0 | — | — | Form 4 |
| Higa Tomohiro | SVP, Finance | Feb 24, 2025 | OTHER | 50,000 | $1.21 | $60.5K | Form 4 |
| Higa Tomohiro | SVP, Finance | Mar 10, 2021 | OTHER | 14,531 | $2.70 | $39.2K | Form 4 |
| Ali Faraz | director, officer: Chief Executive Officer | Feb 6, 2025 | AWARD | 650,000 | $1.00 | $650.0K | Form 4 |
| Ali Faraz | director, officer: Chief Executive Officer | Feb 6, 2025 | AWARD | 401,390 | $1.21 | $485.7K | Form 4 |
| Ali Faraz | director, officer: Chief Executive Officer | Feb 6, 2025 | AWARD | 353,271 | $1.21 | $427.5K | Form 4 |
| Ali Faraz | director, officer: Chief Executive Officer | Feb 6, 2025 | AWARD | 34,424 | — | — | Form 4 |
| Ali Faraz | director, officer: Chief Executive Officer | Feb 6, 2025 | AWARD | 107,500 | — | — | Form 4 |
| Ali Faraz | director, officer: Chief Executive Officer | Feb 6, 2025 | AWARD | 161,214 | $1.21 | $195.1K | Form 4 |
| Ali Faraz | director, officer: Chief Executive Officer | Feb 6, 2025 | DISPOSED | 401,390 | $15.19 | $6.1M | Form 4 |
| Ali Faraz | director, officer: Chief Executive Officer | Feb 6, 2025 | DISPOSED | 353,271 | $5.64 | $2.0M | Form 4 |
| Ali Faraz | director, officer: Chief Executive Officer | Feb 6, 2025 | DISPOSED | 161,214 | $9.36 | $1.5M | Form 4 |